This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zarocostas J . World Health Organization declares A (H1N1) influenza pandemic. BMJ 2009; 338: b2425.
Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009; 460: 1021–1025.
Lapinsky SE . H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010; 38 (4 Suppl): e52–57.
Platzbecker U, Thiede C, Fussel M, Geissler G, Illmer T, Mohr B et al. Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia. Leukemia 2006; 20: 707–714.
Ljungman P . Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant 2001; 7 (Suppl): S5–S7.
Likos AM, Kelvin DJ, Cameron CM, Rowe T, Kuehnert MJ, Norris PJ et al. Influenza viremia and the potential for blood-borne transmission. Transfusion 2007; 47: 1080–1088.
Nichols WG, Guthrie KA, Corey L, Boeckh M . Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300–1306.
Uyeki T . Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med 2009; 361: e110.
Raisch DW, Straight TM, Holodniy M . Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature. Pharmacotherapy 2009; 29: 988–992.
Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175–181.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Rohn, A., Kessler, H., Valentin, T. et al. Prophylactic oseltamivir treatment for prevention of donor–recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment. Bone Marrow Transplant 46, 312–313 (2011). https://doi.org/10.1038/bmt.2010.97
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.97